1. (a) The controlled substances listed in this section are included in Schedule I.

2. (b) Any of the following opiates, including their isomers, esters, ethers, salts and salts of isomers, esters and ethers, unless specifically excepted, whenever the existence of these isomers, esters, ethers and salts is possible within the specific chemical designation:

   1. (1) Acetylmethadol;
   2. (2) Allylprodine;
   3. (3) Alphacetylmethadol (except levo-alphacetylmethadol also known as levo-alpha-acetylmethadol, levomethadyl acetate or “LAAM”);
   4. (4) Alphameprodine;
   5. (5) Alphamethadol;
   6. (6) Benzethidine;
   7. (7) Betacetylmethadol;
   8. (8) Betameprodine;
   9. (9) Betamethadol;
   10. (10) Betaprodine;
   11. (11) Clonitazene;
   12. (12) Dextromoramide;
   13. (13) Dextrorphan;
   14. (14) Diampromide;
   15. (15) Diethylthiambutene;
   16. (16) Dimenoxadol;
   17. (17) Dimepheptanol;
   18. (18) Dimethylthiambutene;
   19. (19) Dioxaphetyl butyrate;
   20. (20) Dipipanone;
   21. (21) Ethylmethylthiambutene;
   22. (22) Etonitazene;
   23. (23) Etoxeridine;
   24. (24) Furethidine;
   25. (25) Hydroxypethidine;
   26. (26) Ketobemidone;
   27. (27) Levomoramide;
   28. (28) Levophenacylmorphan;
   29. (29) Morpheridine;
   30. (30) Noracymethadol;
   31. (31) Norlevorphanol;
   32. (32) Normethadone;
   33. (33) Norpipanone;
   34. (34) Phenadoxone;
   35. (35) Phenampromide;
   36. (36) Phenomorphan;
   37. (37) Phenoperidine;
   38. (38) Piritramide;
   39. (39) Proheptazine;
   40. (40) Properidine;
   41. (41) Racemoramide;
   42. (42) Trimeperidine;
   43. (43) Difenoxin;
   44. (44) Propiram;
   45. (45) Tilidine;
   46. (46) -(59) [Repealed.]

   47. (60) Any fentanyl-related substances including any substance not otherwise controlled in any schedule that is structurally related to fentanyl by one or more of the following modifications:

       1. a. Replacement of the phenyl portion of the phenethyl group by any monocycle, whether or not further substituted in or on the monocycle;
       2. b. Substitution in or on the phenethyl group with alkyl, alkenyl, alkoxyl, hydroxyl, halo, haloalkyl, amino or nitro groups;
       3. c. Substitution in or on the piperidine ring with alkyl, alkenyl, alkoxyl, ester, ether, hydroxyl, halo, haloalkyl, amino or nitro groups;
       4. d. Replacement of the aniline ring with any aromatic monocycle whether or not further substituted in or on the aromatic monocycle;
       5. e. Replacement of the N-propionyl group by another acyl group; and
       6. f. Any modifications not as listed above.

3. (c) Any of the following opium derivatives, their salts, isomers and salts of isomers, unless specifically excepted, whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation:

   1. (1) Acetorphine;
   2. (2) Acetyldihydrocodeine;
   3. (3) Benzylmorphine;
   4. (4) Codeine methylbromide;
   5. (5) Codeine-N-Oxide;
   6. (6) Cyprenorphine;
   7. (7) Desomorphine;
   8. (8) Dihydromorphine;
   9. (9) Etorphine;
   10. (10) Heroin;
   11. (11) Hydromorphinol;
   12. (12) Methyldesorphine;
   13. (13) Methyldihydromorphine;
   14. (14) Morphine methylbromide;
   15. (15) Morphine methylsulfonate;
   16. (16) Morphine-N-Oxide;
   17. (17) Myrophine;
   18. (18) Nicocodeine;
   19. (19) Nicomorphine;
   20. (20) Normorphine;
   21. (21) Pholcodeine;
   22. (22) Thebacon; and
   23. (23) Drotebanol.

4. (d) Any material, compound, mixture or preparation which contains any quantity of the following hallucinogenic substances, their salts, isomers and salts of isomers, unless specifically excepted, whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation:

   1. (1) 3,4-methylenedioxy amphetamine;
   2. (2) 5-methoxy-3,4-methylenedioxy amphetamine;
   3. (3) 3,4,5-trimethoxy amphetamine;
   4. (4) Bufotenine;
   5. (5) Diethyltryptamine;
   6. (6) Dimethyltryptamine;
   7. (7) 4-methyl-2,5-dimethoxylamphetamine;
   8. (8) Ibogaine;
   9. (9) Lysergic acid diethylamide;
   10. (10) Mescaline;
   11. (11) Peyote;
   12. (12) N-ethyl-3-piperidyl benzilate;
   13. (13) N-methyl-3-piperidyl benzilate;
   14. (14) Psilocybin;
   15. (15) Psilocyn;
   16. (16) Thiophene Analog of Phencyclidine;
   17. (17) Ethylamine Analog of Phencyclidine;
   18. (18) Pyrrolidine Analog of Phencyclidine;
   19. (19) Any material, compound, combination, mixture, synthetic substitute or preparation which contains any quantity of marijuana or any tetrahydrocannabinols, their salts, isomers or salts of isomers and is not approved for use by the US Food and Drug Administration;
   20. (20) Parahexyl
   21. (21) 3,4-methylenedioxymethamphetamine (MDMA), its optical, positional and geometric isomers, salts and salts of isomers;
   22. (22) 2, 5-Dimethoxy-4-ethylamphetamine (DOET);
   23. (23) Alpha-ethyltrytamine;
   24. (24) Salvia divinorum;
   25. (25) Salvinorin A; and
   26. (26) [Repealed.]

5. (e) Any material, compound, mixture or preparation which contains any quantity of the following depressant substances, including their salts, isomers and salts of isomers unless specifically excepted, whenever the existence of these salts, isomers and salts of isomers is possible within the specific designation:

   1. (1) Methaqualone.
   2. (2) Gamma Hydroxybutyrate (GHB).

6. (f) Any material, compound, mixture or preparation which contains any quantity of the following stimulant substances, including their salts, isomers and salts of isomers unless specifically excepted, whenever the existence of these salts, isomers and salts of isomers is possible within the specific designation:

   1. (1) Fenethylline;
   2. (2) N-Ethylamphetamine;
   3. (3) Cathinone;
   4. (4) Methcathinone;
   5. (5) Aminorex; and

   6. (6) Synthetic cathinone, which means a substance containing 1 or more of the following chemical compounds:

      1. a. Mephedrone (also known as 4-MMC; 4-Methylephedrone; and 2-(methylamino)-1-(4-methylphenyl)-1-propanone);
      2. b. MDPV (also known as Methylenedioxy Pyrovalerone; 3,4-methylenedioxypyrovalerone; and 1-(1,3-benzodioxol-5-yl)-2-(1-pyrrolidinyl)-1-pentanone);
      3. c. Methylone (also known as M1; bk-MDMA; 3,4-Methylenedioxy-N-methylcathinone; and 1-(1,3-benzodioxol-5-yl)-2-(methylamino)-1-propanone);
      4. d. Naphyrone (also known as O-2482; NRG-1; Naphpyrovalerone; β-Naphyrone; and 1-(2-naphthalenyl)-2-(1-pyrrolidinyl)-1-pentanone);
      5. e. Flephedrone (also known as 4-FMC; and 1-(4-fluorophenyl)-2-(methylamino)propan-1-one);
      6. f. Methedrone (also known as 4-Methedrone; Methoxyphedrine; PMMC; para-Methoxymethcathinone; 4-methoxymethcathinone; and 1-(4-methoxyphenyl)-2-(methylamino)-1-propanone; 4-methoxy methcathinone);
      7. g. Ethcathinone (also known as Ethylpropion, N-ethylcathinone and 2-ethylaminopropiophenone; βk-Ethylamphetamine; 2-ethylaminopropiophenone; and 2-ethylamino-1-phenyl-propan-1-one, N-ethylcathinone);
      8. h. Ethylone (also known as 3,4-methylenedioxy-N-ethylcathinone; MDEC; βk-MDEA; and (RS)-1-(1,3-benzodioxol-5-yl)-2-(ethylami-no)propan-1-one);
      9. i. Butylone (also known as β-keto MBDB; and 1-(1,3-benzodioxol-5-yl)-2-(methylamino)-1-butanone);
      10. j. Metamfepramone (also known as N,N-Dimethylcathinone; and 2-(dimethylamino)-1-phenyl-1-propanone);
      11. k. Alpha-PPP (also known as α-Pyrrolidinopropiophenone; and 1-phenyl-2-(1-pyrrolidinyl)-1-propanone);
      12. l. l. MOPPP (also known as 4′-Methoxy-α-pyrrolidinopropiophenone; and 1-(4-methoxyphenyl)-2-(pyrrolidin-1-yl)propan-1-one);
      13. m. MDPPP (also known as 3′,4′-Methylenedioxy-α-pyrrolidinopropiophenone; and 1-(1,3-benzodioxol-5-yl)-2-(1-pyrrolidinyl)-1-propanone);
      14. n. Alpha-PVP (also known as α-Pyrrolidinopentiophenone; α-PVP; O-2387; alpha-PVP; and 1-phenyl-2-(1-pyrrolidinyl)-1-pentanone);
      15. o. 3-FMC (also known as 3-Fluoromethcathinone; and 1-(3-fluorophenyl)-2-(methylamino)propan-1-one);
      16. p. MPBP (also known as 4′-Methyl-α-pyrrolidinobutiophenone; and (RS)-1-(4-methylphenyl)-2-(1-pyrrolidinyl)-1-butanone); and
      17. q. Methcathinone (also known as α-methylamino-propiophenone; Ephedrone (Europe); and (RS)-2-(methylamino)-1-phenyl-propan-1-one).

7. (g) Any synthetic cannabinoid, which means any material containing any compound, mixture, or preparation that is not a federal Food and Drug Administration (FDA) approved drug and is chemically synthesized to produce a psychotropic response by binding at 1 or more cannabinoid receptors. Synthetic cannabinoid classes include all of the following:

   1. (1) Naphthoylindoles. —

   Any compound containing a 3-(1-naphthoyl)indole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cyc1oalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent. This structural class includes all of the following:

   1. a. JWH 018.
   2. b. JWH 019.
   3. c. JWH 073.
   4. d. JWH 081.
   5. e. JWH 122.
   6. f. JWH 200.
   7. g. JWH 398.
   8. h. AM2201.
   9. i. WIN 55,212.2.
   10. (2) Naphthylmethylindoles. —

   Any compound containing a 1H-indol-3-yl-(1-naphthyl)methane structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2piperidinyl)methyl, or 2-(4-morpho-linyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent. This structural class includes all of the following:

   1. a. JWH 175.
   2. b. JWH 184.
   3. (3) Naphthoylpyrroles. —

   Any compound containing a 3-(1naphthoyl)pyrrole structure with substitution at the nitrogen atom of the pyrrole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the pyrrole ring to any extent and whether or not substituted in the naphthyl ring to any extent. This structural class includes JWH 307.

   1. (4) Naphthylmethylindenes. —

   Any compound containing a naphthylideneindene structure with substitution at the 3-position of the indene ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indene ring to any extent and whether or not substituted in the naphthyl ring to any extent. This structural class includes JWH 176.

   1. (5) Phenylacetylindoles. —

   Any compound containing a 3-phenylacetylindole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent. This structural class includes all of the following:

   1. a. RCS-8 (SR-18).
   2. b. JWH 250.
   3. c. JWH 203.
   4. d. JWH 251.
   5. e. JWH 302.
   6. (6) Cyclohexylphenols. —

   Any compound containing a 2-(3hydroxycyclohexyl)phenol structure with substitution at the 5-position of the phenolic ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not substituted in the cyclohexyl ring to any extent. This structural class includes all of the following:

   1. a. CP 47,497.
   2. b. CP 55,940.
   3. (7) Benzoylindoles. —

   Any compound containing a 3-(benzoyl)indole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent. This structural class includes all of the following:

   1. a. AM694.
   2. b. RCS-4 (SR-19).
   3. c. AM679.
   4. (8) Adamantoylindoles. —

   Any compound containing a 3-(1adamantoyl)indole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the adamantyl ring system to any extent. This structural class includes AM1248.

8. (h) Any material, compound, mixture, or preparation that contains any quantity of tianeptine including its salts, isomers and salts of isomers unless specifically excepted, whenever the existence of these salts, isomers and salts of isomers is possible.

16 Del. C. 1953, § 4714; 58 Del. Laws, c. 424, § 1; 61 Del. Laws, c. 261, §§ 1, 2; 71 Del. Laws, c. 295, § 3; 75 Del. Laws, c. 256, §§ 2, 3; 77 Del. Laws, c. 110, §§ 1, 2; 78 Del. Laws, c. 61, § 2; 15 DE Reg 577 (Emergency); 78 Del. Laws, c. 204, §§ 3, 4; 81 Del. Laws, c. 77, § 1; 81 Del. Laws, c. 401, § 1; 82 Del. Laws, c. 120, § 1; 83 Del. Laws, c. 335, § 1; 85 Del. Laws, c. 87, § 1